High-Sensitivity ELISA Kits for Therapeutic Protein Monitoring

The advances in the development and use of therapeutic proteins have brought significant benefits to medical care, from diabetes to cancer. However, it is often challenging to accurately monitor the proteins because they are complex biological substances. The high-sensitivity ELISA kit can be a good choice for scientists and doctors to quantitatively measure the therapeutic proteins at low concentrations, which is beneficial for the pharmacokinetic study and the therapeutic drug monitoring.

Figure 1. Therapeutic Protein Monitoring. (Griss, Rudolf, et al. 2014)

The Critical Role of Therapeutic Protein Monitoring

The progress of therapeutic proteins has brought us unprecedented treatment of diseases, such as cancer, autoimmune diseases, infectious diseases and genetic diseases. High sensitivity ELISA kits can provide excellent support in the following areas:

PK studies: PK studies measure the long-term effects of drugs on human body including absorption, distribution, metabolism and excretion. Quantification of therapeutic protein concentration in biological samples (serum and plasma) is important for setting proper dosing regimens, predicting drug exposure and studying drug distribution. With the high-sensitivity ELISA kit, therapeutic protein concentrations can be measured at various levels from initial high doses to trough concentrations.

PD studies: PD studies assess the effects of drugs on the human body including the mechanism of action and the extent of the therapeutic effect. Therapeutic protein effects can be measured through various biomarkers. However, understanding the relationship between drug concentration and response often requires PK data obtained through high-sensitivity detection.

Immunogenicity assessment (ADA testing): Therapeutic proteins are often highly immunogenic and can be neutralized by patient-generated drug-resistant antibodies (ADA). ADA neutralizes the activity of therapeutic proteins, affects PK and may also cause adverse immune reactions.

Components of High - Sensitivity ELISA Kits

• Antibodies: High – sensitivity ELISA kits use monoclonal or polyclonal antibodies that are highly specific to the therapeutic protein. Antibodies are pre – coated onto the microplate wells in most commercial kits to ensure that the assays are reproducible and standardized.
• Enzyme Conjugates: HRP and AP are commonly used as enzyme conjugates in these kits to generate the signal. In high – sensitivity kits, the conjugates are optimized for high activity and low background. The conjugation process is carefully controlled to maintain enzyme activity without compromising the antibody binding ability.
• Standards and Controls: High - sensitivity ELISA kits typically come with calibrated standards of the therapeutic protein. These standards are used to generate a standard curve to determine the concentration of the protein in unknown samples. The standards typically span a range of concentrations that covers the expected physiological or therapeutic range of the protein. Quality control samples are also included to ensure the assay is functioning properly.
• Buffers and Substrates: Wash buffers are used to remove unbound components at each step of the assay to reduce background signal. The composition of these buffers is carefully optimized to maintain the stability of the antigen - antibody interactions. The substrates used for the enzymes are chosen to produce a strong and stable signal.

Advanced ELISA Solutions for Therapeutic Protein Monitoring

Our ELISA kit or Therapeutic Protein Monitoring series are designed to support the entire lifecycle of protein drug development.. These solutions utilize innovative detection chemistry and proprietary antibody pairs to provide excellent sensitivity and extremely low cross reactivity, ensuring reliable data even in the most challenging sample types. The main products include: